Pivotal Phase 3 4WARD clinical trial is evaluating use of oral mavorixafor as monotherapy and in combination with injectable G-CSFBOSTON,…
Daré Bioscience’s DARE-LARC1 Platform Technology has Transformative Potential for Women’s Health as well as in Treating a Broad Range of…
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…
NEW YORK, Dec. 3, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global in-vitro and…
SAN DIEGO, CA / ACCESSWIRE / December 3, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage…
Partners working to expand program after successful six-month pilot study at North Mississippi Medical Center, which enabled production of 12,000…
Richardson brings 25+ years of experience navigating complex drug-pricing and access challenges WASHINGTON, Dec. 3, 2024 /PRNewswire/ -- Global expert…
The Acquisition of NexGenAI Affiliates Network Expands Company's Capabilities and Drives Innovation, Operational Efficiency, and Opportunity for Growth WEXFORD, Pa. ,…
Long-standing, global firm innovates with new on-demand talent solutions, executive coaching, and board advisory as part of new strategic transition…
WOBURN, MA / ACCESSWIRE / December 3, 2024 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing…